Yi Lü
Impact in
- Oncology top 2%
- Bone health and treatments
- Chemokine receptors and signaling
- Cancer Cells and Metastasis
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
- Oncology 37
- Bone health and treatments 9
- Cancer Immunotherapy and Biomarkers 8
- Chemokine receptors and signaling 5
- Cancer Cells and Metastasis 4
-
- Bone Metabolism and Diseases 7
- Co-authors
- Evan T. Keller (22 shared papers)Jian Zhang (21 shared papers)Zhi Yao (10 shared papers)Jinlu Dai (9 shared papers)Jian Zhang (7 shared papers)Atsushi Mizokami (9 shared papers)Guozhi Xiao (5 shared papers)Zhejun Cai (9 shared papers)
- Journals
- Cancer Research (7 papers)The Prostate (3 papers)Chinese Journal of Cancer (3 papers)Oncology Reports (3 papers)Frontiers in Cardiovascular Medicine (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yi Lü
109 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 138
- Oncology 1.1k
- Cancer Research 558
- Immunology 524
- Molecular Biology 1.4k
- Pulmonary and Respiratory Medicine 598
Countries citing papers authored by Yi Lü
This map shows the geographic impact of Yi Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Lü more than expected).
Fields of papers citing papers by Yi Lü
This network shows the impact of papers produced by Yi Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Lü. The network helps show where Yi Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 187 | |
| 2 | 2005 | 171 | |
| 3 | 2021 | 168 | |
| 4 | 2009 | 159 | |
| 5 | 2007 | 140 | |
| 6 | Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone. | 2003 | 130 |
| 7 | 2006 | 120 | |
| 8 | 2007 | 110 | |
| 9 | 2008 | 93 | |
| 10 | 2015 | 92 | |
| 11 | 1998 | 82 | |
| 12 | 2019 | 80 | |
| 13 | 2016 | 76 | |
| 14 | 2016 | 74 | |
| 15 | 2017 | 72 | |
| 16 | 2008 | 69 | |
| 17 | 2009 | 68 | |
| 18 | 2019 | 62 | |
| 19 | 2023 | 58 | |
| 20 | 2007 | 56 |
About Yi Lü
Yi Lü is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 115 papers that have together received 3.5k indexed citations. Recurring topics across this work include Bone health and treatments (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Bone Metabolism and Diseases (7 papers), Advanced Fiber Laser Technologies (7 papers), Nonlinear Photonic Systems (6 papers), Immunotherapy and Immune Responses (5 papers), Chemokine receptors and signaling (5 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (558 citations), Immunology (524 citations), Molecular Biology (1.4k citations) and Pulmonary and Respiratory Medicine (598 citations). Yi Lü has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Evan T. Keller, Jian Zhang, Zhi Yao, Jinlu Dai, Jian Zhang, Atsushi Mizokami, Guozhi Xiao, Zhejun Cai, Zhong Cai and Jill M. Keller. Their work appears in journals such as Cancer Research, The Prostate, Chinese Journal of Cancer, Oncology Reports and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.